Influence of Lipiodol Agent on Proton Beam Range in Radiotherapy Planning Using Computed Tomography for Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 3, 2008, Pages 687-694

  Shin, Dongho ^a   Kim, Tae Hyun ^a   Park, Sung Yong ^a   Kwak, Jungwon ^a   Moon, Sung Ho ^a   Yoon, Myonggeun ^a   Lee, Se Byeong ^a   Park, Soah ^a   Shin, Kyung Hwan ^a   Kim, Dae Yong ^a   Cho, Kwan Ho ^a   Park, Joong Won ^a   Kim, Chang Min ^a  

^a National Cancer Center   (South Korea)

Author keywords

Hounsfield unit; Lipiodol; Proton

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC RADIOGRAPHY; ELECTRIC INSTRUMENT TRANSFORMERS; ELECTROTHERAPEUTICS; IMAGE ENHANCEMENT; IMAGING TECHNIQUES; MEDICAL IMAGING; PARTICLE BEAMS; PROTON BEAMS; PROTONS; THERMOGRAPHY (TEMPERATURE MEASUREMENT); TOMOGRAPHY; WATER RECYCLING;

COMPUTED TOMOGRAPHY; CT IMAGING; DATA SETS; HEPATOCELLULAR CARCINOMA; HOUNSFIELD UNIT; LIPIODOL; MEASURED VALUES; NORMAL TISSUES; PROTON; RADIOTHERAPY PLANNING; TREATMENT PLANNING SYSTEMS; WATER PHANTOM;

WATER TREATMENT;

IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING;

ADULT; AGED; CALIBRATION; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTONS; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; WATER;

EID: 52949135918     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.01.059     Document Type: Article

References (28)

1. Parkin D.M., Bray F., Ferlay J., et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
2. Tsuzuki T., Sugioka A., Ueda M., et al. Hepatic resection for hepatocellular carcinoma. Surgery 107 (1990) 511-520
3. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 359 (2002) 1734-1739
4. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
5. Sasaki Y., Imaoka S., Kasugai H., et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 60 (1987) 1194-1203
6. Yu Y.Q., Xu D.B., Zhou X.D., et al. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 71 (1993) 62-65
7. Ingold J.A., Reed G.B., Kaplan H.S., et al. Radiation hepatitis. AJR Am J Roentgenol Radium Ther Nucl Med 93 (1965) 200-208
8. Lewin K., and Millis R.R. Human radiation hepatitis: A morphologic study with emphasis on the late changes. Arch Pathol 96 (1973) 21-26
9. Cheng S.H., Lin Y.M., Chuang V.P., et al. A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol 14 (1999) 1025-1033
10. Kim D.Y., Park W., Lim D.H., et al. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 103 (2005) 2419-2426
11. Kim T.H., Kim D.Y., Park J.W., et al. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable. Am J Clin Oncol 29 (2006) 568-575
12. Seong J., Park H.C., Han K.H., et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 47 (2000) 1331-1335
13. Kim T.H., Kim D.Y., Park J.W., et al. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 225-231
14. Ishikura S., Ogino T., Furuse J., et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol 25 (2002) 189-193
15. Seong J., Keum K.C., Han K.H., et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 393-397
16. Tazawa J., Maeda M., Sakai Y., et al. Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol 16 (2001) 660-665
17. Kozak K.R., Katz A., Adams J., et al. Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys 65 (2006) 1572-1578
18. Trofimov A., Nguyen P.L., Coen J.J., et al. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: A treatment planning comparison. Int J Radiat Oncol Biol Phys 69 (2007) 444-453
19. Bush D.A., Hillebrand D.J., Slater J.M., et al. High-dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial. Gastroenterology 127 (2004) S189-S193
20. Hata M., Tokuuye K., Sugahara S., et al. Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer 104 (2005) 794-801
21. Kawashima M., Furuse J., Nishio T., et al. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 23 (2005) 1839-1846
22. Kanematsu N., Matsufuji N., Kohno R., et al. A CT calibration method based on the polybinary tissue model for radiotherapy treatment planning. Phys Med Biol 48 (2003) 1053-1064
23. Schaffner B., and Pedroni E. The precision of proton range calculations in proton radiotherapy treatment planning: Experimental verification of the relation between CT-HU and proton stopping power. Phys Med Biol 43 (1998) 1579-1592
24. Schneider U., Pedroni E., and Lomax A. The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys Med Biol 41 (1996) 111-124
25. Choi Y., Kim J.K., Lee H.S., et al. Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer. Radiother Oncol 81 (2006) 158-162
26. Shibamoto Y., Naruse A., Fukuma H., et al. Influence of contrast materials on dose calculation in radiotherapy planning using computed tomography for tumors at various anatomical regions: A prospective study. Radiother Oncol 84 (2007) 52-55
27. Wertz H., and Jakel O. Influence of iodine contrast agent on the range of ion beams for radiotherapy. Med Phys 31 (2004) 767-773
28. Cormier J.N., Thomas K.T., Chari R.S., and Pinson C.W. Management of hepatocellular carcinoma. J Gastrointest Surg 10 (2006) 761-780